Form 8-K - Current report:
SEC Accession No. 0001193125-26-333912
Filing Date
2026-08-05
Accepted
2026-08-05 08:05:10
Documents
13
Period of Report
2026-08-05
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d166048d8k.htm   iXBRL 8-K 26296
2 EX-99.1 d166048dex991.htm EX-99.1 94357
6 GRAPHIC g166048dsp009.jpg GRAPHIC 3780
  Complete submission text file 0001193125-26-333912.txt   256310

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA ima-20260805.xsd EX-101.SCH 3192
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE ima-20260805_lab.xml EX-101.LAB 18735
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ima-20260805_pre.xml EX-101.PRE 11716
17 EXTRACTED XBRL INSTANCE DOCUMENT d166048d8k_htm.xml XML 3789
Mailing Address 12526 HIGH BLUFF DRIVE SAN DIEGO CA 92130
Business Address 12526 HIGH BLUFF DRIVE SAN DIEGO CA 92130 857-343-8292
ImageneBio, Inc. (Filer) CIK: 0001835579 (see all company filings)

EIN.: 811697316 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40287 | Film No.: 261241411
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)